Analyst Ratings for Bristol-Myers Squibb Co. (BMY) [Sells]
BMY Rating Summary
BMY Price Target Summary
- Highest: $90.00 (Citi)
- Lowest: $40.00 (Morgan Stanley)
- Average: $59.45
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$59.45 (+21%)
* Over Last 12-Mos
Rating Score: 1.7 / 10
Percentile Rank: 12%
Rating Score: 1.7 / 10
Percentile Rank: 12%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/6/2022 | Morgan Stanley » Updated 4/9/2024 |
Matthew Harrison | Downgrade | Underweight (Equalweight) |
40.00 (41.00) |
73.79 (49.14) |
-33.41% | Details |
| 10/28/2011 | CLSA | N/A | Downgrade | Underperform (4) (N/A) |
35.00 (N/A) |
32.62 (49.14) |
50.64% | Details |
 |
||||||||
